Insulin by Jet-injection for Hyperglycemia in Diabetes

Summary

The purpose of this study is to compare the pharmacokinetic and pharmacodynamic profile of the rapid-acting insulin analogue aspart (Novorapid®) injected subcutaneously by jet-injection to that of the same insulin injected with a conventional pen in the management of hyperglycemia in subjects with diabetes

Timeline

Start

2014-03

Primary completion

2014-11

Completion

2014-11

Drugs

Indications